Focus of the company is to provide clients with a wide range of drug development expertise/services from discovery to IND filing, bioanalytical methods, metabolism, clinical development plans/execution, pre-clinical/clinical pharmacology, translational medicine, regulatory and NDA submission. MaierMetrics is organized on a cost effective project team basis, led by associates with proven track records of success and individually with over 25 years of pharmaceutical experience including rare… Show more Focus of the company is to provide clients with a wide range of drug development expertise/services from discovery to IND filing, bioanalytical methods, metabolism, clinical development plans/execution, pre-clinical/clinical pharmacology, translational medicine, regulatory and NDA submission. MaierMetrics is organized on a cost effective project team basis, led by associates with proven track records of success and individually with over 25 years of pharmaceutical experience including rare diseases, oncology, microbiome, cell based modalities and CNS. Our president and associates have filed numerous IND's/market applications to FDA and global health authorities that led to products such as Lunesta, Brovana and Xopenex, franchises (among others), as well as key regulatory milestone briefing documents. In addition we are well versed and powerful advocates of model based drug development and knowledge integration across all phases of the development process. Show less